Lyxumia

Pharma

Sanofi nabs long-sought FDA nod for diabetes med Adlyxin

Sanofi finally won FDA approval of its long-awaited GLP-1 diabetes drug Adlyxin. But “finally” is the operative word, and the med will have to scramble with new and formidable rivals to win market share.

Tracy Staton Jul 28, 2016 9:56am